Immunology

Immune Checkpoint Blockade

Anti-PD-1/PD-L1
Pembrolizumab
Nivolumab
Cemiplimab
Sintilimab
Spartalizumab
Atezolizumab
Durvalumab
Avelumab
Anti-CTLA-4
Ipilimumab
Tremelimumab
Zalifrelimab
Quavonlimab
Anti-LAG-3
Relatlimab
Anti-VISTA
CA-170
NSC622608
Anti-CD47
Magrolimab
Anti-CD47
Anti-TIM-3
Sabatolimab
Cobolimab
Anti-TIGIT
Tiragolumab
Vibostolimab
Anti-B7-H3 (CD276)
Enoblituzumab
Omburtamab
Anti-BTLA (CD272)
Icatolimab

Immunosuppressants

Cytotoxic Molecules [13]
Cyclophosphamide
Busulfan
Cisplatin
Ifosfamide
Thiotepa
Antimetabolites
Mycophenolate mofetil
Azathioprine
Calcineurin Inhibitors
Cyclosporine
Cyclosporin A
Tacrolimus
Pimecrolimus
Immunoproteasome Inhibitors
Bortezomib
Carfilzomib
Sotrastaurin
Immunosuppressive Antibodies
Tocilizumab
Rituximab
Belimumab
Eculizumab
Obinutuzumab
Sutimlimab
Siplizumab